Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover the novel CN111499572A patent route for Roxadustat intermediates. Achieve high purity and cost reduction in API manufacturing with our scalable technology.
Discover a novel, cost-effective synthesis route for Roxadustat intermediates. This patent-based analysis highlights high-yield cyclization and supply chain advantages.
Patent CN116848257A enables green production of (R)-mandelic acid. Achieve cost reduction in pharmaceutical intermediates manufacturing with sustainable enzyme cascades.
Patent CN103360250A reveals a novel ZnCl2-catalyzed acetylation route for Diacerein, eliminating toxic chromium reagents and ensuring high purity for osteoarthritis drug manufacturing.
Novel one-step synthesis of chiral oxazolines using ZnCl2 offers high purity and cost efficiency for asymmetric catalysis applications in drug discovery.
Patent CN118459319A introduces visible light catalysis for biphenols. Offers green synthesis, cost reduction, and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN108689825B details a robust method for synthesizing 2-(trifluoroethylene/difluoroethyl)-1,3-diketones, offering high-purity fluorine materials for pharmaceutical and agrochemical applications.
Discover the novel 8-step synthesis for tissue-selective estrogen intermediates. Eliminate chromatography, reduce costs, and ensure high-purity supply chain continuity.
Patent CN1070398A details anhydrous acylation for Cefepime. Reduces isomers, improves stability, lowers manufacturing costs for global supply chains.
Novel chiral synthesis via diketopiperazine avoids toxic cyanide. High yield, scalable process for selenium supplements and pharmaceutical intermediates.
Patent CN1898193A details a lithium-catalyzed method for producing bisamido alcohols, offering a safer, high-yield alternative to acyl chloride routes for asymmetric catalyst ligands.
Patent CN115919817B reveals electrochemical and iodine-catalyzed synthesis for high-purity gem-diselenide compounds, offering cost reduction and scalable supply chain solutions.
Patent CN103159776A details a novel total synthesis of Concentricolide. This report analyzes the scalable Michael-Aldol route for cost-effective API intermediate manufacturing.
Patent CN107531662A reveals a scalable Nebivolol synthesis route avoiding chromatography. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN106866364A details a green two-step route from furfuryl alcohol. Offers significant cost reduction and supply chain reliability for fine chemical manufacturing.
Novel synthesis route for DGAT-1 inhibitor intermediate offering high purity and cost reduction in pharma manufacturing without heavy metal residues for reliable supply.
Patent CN115850107B reveals a novel 3-step industrial synthesis improving yield and safety for global pharmaceutical intermediates supply chains significantly and reliably.
Patent CN109651211A details a safer Unithiol method. Achieves high purity and yield. Offers supply chain stability for pharmaceutical manufacturers.
Novel 3-step synthesis offers high purity and yield. Reduces environmental impact and cost for pharma manufacturing supply chains significantly for buyers.
Patent CN102249887A details a TS-1 catalyzed oxidation route for Vitamin K intermediates, offering superior selectivity and reduced environmental impact compared to chromium methods.